HIV Monitoring: Essential Laboratory Tests for Patients
Regular laboratory monitoring is critical for managing HIV infection, assessing treatment efficacy, and preventing complications.
Core Monitoring Tests
1. HIV Viral Load (HIV-1 RNA)
- Measures viral replication level in blood
- Goal: Undetectable (<50 copies/mL) on ART
- Frequency: At diagnosis, 2-4 weeks after ART initiation, then every 3-6 months
- Detects virologic failure early
2. CD4+ T-Cell Count
- Measures immune system strength
- <500 cells/µL: Immune suppression; <200: AIDS-defining
- Frequency: At diagnosis, every 3-6 months (less frequent if stable on ART)
- Guides opportunistic infection prophylaxis
3. Complete Blood Count (CBC)
- Red blood cells (anemia), white blood cells (infection risk), platelets (bleeding risk)
- Monitor for ART toxicity (zidovudine → anemia/neutropenia)
- Frequency: Every 3-6 months
4. Liver Function Tests (LFTs)
- ALT, AST, ALP, bilirubin, albumin
- Monitor for ART hepatotoxicity (NNRTIs, PIs), viral hepatitis coinfection, fatty liver
- Frequency: Every 3-6 months
5. Renal Function Tests
- Creatinine, eGFR, BUN
- Monitor for tenofovir (TDF) nephrotoxicity, HIV-associated nephropathy (HIVAN)
- Frequency: Every 3-6 months (more often if risk factors)
6. Lipid Profile
- Total cholesterol, LDL, HDL, triglycerides
- ART (especially PIs) can cause dyslipidemia → cardiovascular risk
- Frequency: Baseline, then annually or more often if abnormal
7. Hepatitis B & C Serology
- HBsAg, anti-HBc, anti-HBs (HBV); anti-HCV, HCV RNA (HCV)
- Coinfection affects ART selection and liver disease progression
- Test at baseline; vaccinate if HBV susceptible
8. Drug Resistance Testing
- Genotypic resistance assay (standard)
- At baseline, virologic failure, pre-conception
- Guides ART regimen selection
9. HIV Genotyping/Subtyping
- Identifies HIV-1 subtype (B predominant in US/EU; non-B globally)
- May influence drug resistance patterns and treatment choices
Additional Monitoring
- Urinalysis (proteinuria for HIVAN/tenofovir)
- Bone density (DEXA) for older adults/long-term ART
- Cardiovascular risk assessment
- STI screening (syphilis, gonorrhea, chlamydia)
- Cancer screening per guidelines
Testing frequency individualized based on clinical status, treatment phase, and guidelines (DHHS, IAS-USA, WHO).
HIV & AIDS - Related Articles
- Understanding the Physical Signs of AIDS (HIV Infection)
- HIV Antibody Screening of Blood Donations: ELISA Algorithm and Safety
- Mother-to-Child HIV Transmission: Facts and Prevention
- HIV/AIDS Dating Sites: Connecting & Finding Support - PositiveSingles, iCrushed & More
- PCP (Pneumocystis Pneumonia) and HIV: Not Always Linked
- Biktarvy for HIV: Mechanism, Efficacy & Clinical Profile
- Acute HIV Infection (Seroconversion Syndrome): Symptom Profile and Testing Window
